Global Leaders in Mobile ECG Connectivity
- 20 years of medical credibility licensing technologies to hospitals, physicians, remote patient monitoring platforms, research groups and commercial call centers
- Sold into > 20 countries, with the largest customer base located in the US
- Class II medical device clearances and device agnostic for collecting, viewing, recording, analyzing and storing of ECGs for management of patient and consumer health
- ECG solutions for both consumer (OTC) and medical (Rx) markets
- Owns all IP and source code
- Market expert contributor for reports in mâ€health, mobile cardiac monitoring and new advances in consumer health and wellness monitoring
Recent Highlights
CardioComm Solutions Partners with CareOS to Bring Consumer ECG Monitoring into the Connected Home
- Entered into a partnership agreement with CareOS SAS (France), a subsidiary of Baracoda Group, to provide consumer ECG monitoring technologies through the CareOS Poseidon smart mirror health and beauty hub
- The partnership will see CardioComm’s FDA and Health Canada cleared GEMS™ ECG management software and Smart Monitoring ECG reading service integrated into the touch and gesture controlled smart mirror
- GEMSTM software will be capable of recognizing ECG devices made by multiple device manufacturers which will permit CareOS customers more options in choosing a device of their preference.
Industry News
- INDUSTRY BULLETIN: Global Smart Home Healthcare Market is predicted to grow to $30 billion by 2023
- INDUSTRY BULLETIN: mHealth Project to Crowdsource Consumer Data for Coronavirus Research
- INDUSTRY BULLETIN: ‘Smart’ devices help reduce adverse outcomes of common heart condition
- INDUSTRY BULLETIN: The Tech That Could Be Our Best Hope for Fighting COVID-19—and Future Outbreaks
Company Accolades
FULL DISCLOSURE: CardioComm Solutions Inc. is an advertising client of AGORA Internet Relations Corp.
Tags: investments, mhealth, small cap stocks, Smart apps, stocks, tsx